Cargando…

Advantages of 6% hydroxyethyl starch 130/0.4 (Voluven(®)) at repetitive high dose levels in patients with severe cranio-cerebral trauma

Detalles Bibliográficos
Autores principales:	Neff, ThA, Jungheinrich, C, Doelberg, M, Sauerland, A, Spahn, DR, Stocker, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333301/ http://dx.doi.org/10.1186/cc1181

Ejemplares similares

Is hydroxyethyl starch 130/0.4 safe?
por: Haase, Nicolai, et al.
Publicado: (2012)

Effect of 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride (Voluven®) on complications after subarachnoid hemorrhage: a retrospective analysis
por: Khan, Shariq A, et al.
Publicado: (2013)

Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: a propensity-matched analysis
por: Van der Linden, Philippe, et al.
Publicado: (2015)

Volume substitution therapy with HES 130/0.4 (Voluven(®)) versus HES 450/0.7 (hetastarch) during major orthopedic surgery
por: Gandhi, S, et al.
Publicado: (2005)

Comparing the Effects of 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 (Voluven) on Renal Function as Priming Solutions for Cardiopulmonary Bypass: A Randomized Double Blind Clinical Trial
por: Hosseinzadeh Maleki, Mahmood, et al.
Publicado: (2016)

Comparison of the Effectiveness of Hydroxyethyl Starch (Voluven) Solution With Normal Saline in Hemorrhagic Shock Treatment in Trauma
por: Masoumi, Kambiz, et al.
Publicado: (2016)

Assessment of coagulation with 6% hydroxyethyl starch 130/0.4 in cesarean section
por: Oh, Chung-Sik, et al.
Publicado: (2012)

The impact of 30 ml/kg hydroxyethyl starch 130/0.4 vs hydroxyethyl starch 130/0.42 on coagulation in patients undergoing abdominal surgery
por: Staikou, Chryssoula, et al.
Publicado: (2012)

Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double-blind clinical trial
por: Béchir, Markus, et al.
Publicado: (2013)

Update on transfusion solutions during surgery: review of hydroxyethyl starches 130/0.4
por: Piazza, Ornella, et al.
Publicado: (2010)

Interactions between the volume effects of hydroxyethyl starch 130/0.4 and Ringer´s acetate
por: Hahn, Robert G, et al.
Publicado: (2013)

Effects of hydroxyethyl starch 130/0.4 on the kidney tissue of rats with ureteral obstruction
por: Güneş, Işın, et al.
Publicado: (2018)

Pharmacokinetics and tolerability of intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%) in 19 subjects with mild to severe renal impairment: terminal half life and peak concentration (C(max))remain unaffected
por: Jungheinrich, C, et al.
Publicado: (2001)

Haemodynamic effects of a fluid challenge with hydroxylethyl starch 130/0.4 (Voluven(®)) in patients suffering from symptomatic vasospasm after subarachnoid haemorrhage
por: Van Tulder, L, et al.
Publicado: (2008)

In vivo effect of hydroxyethyl starch solution (HES 130/0.4) on different fibrinogen assays
por: Schött, U, et al.
Publicado: (2014)

Large-dose hydroxyethyl starch (HES) 130/0.4 in elective coronary artery bypass surgery
por: Kasper, SM, et al.
Publicado: (2002)

Evaluation of effectiveness and safety of hydroxyethyl starch (HES 130 kDa/0.4) in burn resuscitation
por: Mokline, A, et al.
Publicado: (2012)

Hydroxyethyl starch 130/0.4 and sodium chloride injection as adjunctive therapy in patients with cerebral hypoperfusion
por: Han, Junliang, et al.
Publicado: (2012)

Hydroxyethyl starch 130/0.4 or hypertonic saline solution to decrease inflammatory response in hemorrhagic shock?
por: Esnault, Pierre, et al.
Publicado: (2013)

Resuscitation with hydroxyethyl starch 130/0.4 attenuates intestinal injury in a rabbit model of sepsis
por: Lu, Wei-Hua, et al.
Publicado: (2015)

Comparison of Hydroxyethyl starch 130/0.4 (6%) with commonly used agents in an experimental Pleurodesis model
por: Kapicibasi, Hasan Oğuz, et al.
Publicado: (2020)

Comparison of 6% HES 130/0.4 in a balanced electrolyte solution versus 6% HES 130/0.4 in saline solution in cardiac surgery
por: Base, E, et al.
Publicado: (2006)

Perioperative clinical and economic outcomes associated with replacing first-generation high molecular weight hydroxyethyl starch (Hextend®) with low molecular weight hydroxyethyl starch (Voluven®) at a large medical center
por: Bartz, Raquel R, et al.
Publicado: (2015)

Hydroxyethyl starch HES 130/0.4 in paediatric surgery: results of an explorative, controlled, multicentre safety study
por: Lochbühler, H, et al.
Publicado: (2003)

Human albumin and 6% hydroxyethyl starches (130/0.4) in cardiac surgery: a meta-analysis revisited
por: Wiedermann, Christian J.
Publicado: (2022)

Effects of synthetic colloids on oxidative stress and inflammatory response in hemorrhagic shock: comparison of hydroxyethyl starch 130/0.4, hydroxyethyl starch 200/0.5, and succinylated gelatin
por: Chen, Gan, et al.
Publicado: (2013)

Blood substitutes consumption and coagulation changes: 200/0.5 vs 130/0.4 hydroxyethyl starch administration
por: Costa, MG, et al.
Publicado: (2003)

Effects of Hydroxyethyl Starch 130/0.4 on Serum Creatinine Concentration and Development of Acute Kidney Injury in Nonazotemic Cats
por: Sigrist, N.E., et al.
Publicado: (2017)

Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction
por: Trentini, Alessandro, et al.
Publicado: (2019)

Renal Morbidity of 6% Hydroxyethyl Starch 130/0.4 in 9000 Propensity Score Matched Pairs of Surgical Patients
por: Miyao, Hideki, et al.
Publicado: (2019)

Stage 1-Biomarkers of Kidney Injury in Dogs Undergoing Constant Rate Infusion of Hydroxyethyl Starch 130/0.4
por: Bruno, Barbara, et al.
Publicado: (2021)

Biomarkers of Coagulation and Inflammation in Dogs after Randomized Administration of 6% Hydroxyethyl Starch 130/0.4 or Hartmann’s Solution
por: Boyd, Corrin J., et al.
Publicado: (2022)

Effect of 6% Hydroxyethyl Starch 130/0.4 as a Priming Solution on Coagulation and Inflammation Following Complex Heart Surgery
por: Cho, Jang-Eun, et al.
Publicado: (2014)

Adverse effects of hydroxyethyl starch (HES 130/0.4) on intestinal barrier integrity and metabolic function are abrogated by supplementation with Albumin
por: Wong, Yuk Lung, et al.
Publicado: (2016)

Thromboelastometric assessment of hemostasis following hydroxyethyl starch (130/0.4) administration as a constant rate infusion in hypoalbuminemic dogs
por: Botto, Angelica, et al.
Publicado: (2018)

Evaluation of renal injury caused by acute volume replacement with hydroxyethyl starch 130/0.4 or Ringer's lactate solution in pigs
por: Ferreira, David A., et al.
Publicado: (2018)

Effect of acute hypervolemic hemodilution of 6% hydroxyethyl starch 130/0.4 on the EC(50) of propofol at two clinical endpoints in patients
por: LI, YUHONG, et al.
Publicado: (2016)

Low-quality Trials as a Source of Heterogeneity in the Association of Hydroxyethyl Starch 130/0.4 or 0.42 with Excess Mortality in Sepsis
por: Wiedermann, Christian J
Publicado: (2016)

The comparison of albumin and 6% hydroxyethyl starches (130/0.4) in cardiac surgery: a meta-analysis of randomized controlled clinical trials
por: Wei, Ling, et al.
Publicado: (2021)

Effect of 6% hydroxyethyl starch 130/0.4 on kidney and haemostatic function in cardiac surgical patients: a randomised controlled trial
por: Duncan, A. E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p8e2pcfef2u9op0l15emv3a04f